Hepatic involvement in multiple myeloma is not common; nevertheless, it is associated with poorer outcome. Heterogeneous features have been described in few published reports so far. We present the imaging findings of PET/CT in comparison to those of MRI for two multiple myeloma (MM) patients, one with a liver lesion suspicious for myeloma metastasis on PET and one with multiple liver lesions suspicious for myeloma metastases on MRI. The subsequent ultrasound-guided needle biopsies confirmed the extramedullary spread of the disease in both patients. The first case exhibited a match in both functional imaging modalities (PET and MRI) but a mismatch of intense metabolic activity on 18 F-fluorodeoxyglucose (18F-FDG) PET/CT and iso-attenuating liver parenchyma on contrast-enhanced CT. The second case showed a mismatch of signal elevation persistence on diffusion-weighted imaging (DWI) and physiologic 18F-FDG distribution in the liver parenchyma. These cases present different imaging features in MM lesions of the liver using PET/CT and MRI, reflecting the high disease heterogeneity in patients with MM and demonstrating that the use of both PET/CT and MRI may offer complementary information. and MRI, reflecting the high disease heterogeneity in patients with MM and demonstrating that the use of both PET/CT and MRI may offer complementary information.
. Newly diagnosed patient with multiple myeloma (MM, Typ IgA Kappa, Stage IIIA according to the Durie-Salmon staging system, ISS III), anemia and hepatosplenomegaly underwent an 18F-FDG PET/CT and a routine whole-body MRI investigation, as it is standard for all MM patients. The transaxial fused PET/CT image (a) shows a circumscribed lesion in the IVb segment of the liver (red arrow) with an SUVmax of 10.1, a functional volume of approx. 90 ml and a hypometabolic center. At the same level, a cystic liver lesion of 9 cm in diameter is delineated (without FDG-uptake). The FDG-avid lesion is not distinguishable in the low-dose CT (b). The contrast-enhanced diagnostic CT (c) shows a contrast uptake in the arterial phase nearly similar to the liver parenchyma, and a hypodense core demarks itself as in the PET/CT-image. Diffusion-weighted (DW d,e) MRI demonstrates an inhomogeneous abnormal diffusion restriction in the same area (green arrows), which can be clearly distinguished, showing an intermediate T1-signal intensity and a hyperintense core (yellow arrow) in the contrast-enhanced MRI (f). A biopsy of the lesion under sonographic control indicated plasma cell neoplasia. A diagnostic ultrasound of the liver was not performed before (no pre-described MM hepatic disease). The presence of extramedullary lesions at any time during the course of MM indicates a poor prognosis [1] , and these patients may need to follow additional treatment strategies [2, 3] . arrows), which can be clearly distinguished, showing an intermediate T1-signal intensity and a hyperintense core (yellow arrow) in the contrast-enhanced MRI (f). A biopsy of the lesion under sonographic control indicated plasma cell neoplasia. A diagnostic ultrasound of the liver was not performed before (no pre-described MM hepatic disease). The presence of extramedullary lesions at any time during the course of MM indicates a poor prognosis [1] , and these patients may need to follow additional treatment strategies [2, 3] . however, they added that in some areas, the use of both techniques could offer complementary information [4] . It must be noted that small lesions with a subcentimeter size may not be detectable on 18F-FDG PET, due to volume averaging in relation to the limited spatial resolution of the PET scanner [5] . This case report confirms the presumption of Chen et al. and reflects the high disease heterogeneity in patients with MM. A contrast-enhanced CT-scan was not performed in this case. The subsequent 18F-FDG PET/CT (a,b) did not demonstrate any focal lesion in the liver. A small lesion of 8 mm was delineated in Segment IVb, with an abnormal diffusion restriction in diffusion-weighted (DW, c) MRI (red arrow). The same lesion could not be distinguished in the T1-VIBE or T2-weighted sequences (d). A diagnostic ultrasound of the liver was not performed before (no pre-described hepatic disease), while the biopsy of the lesion under sonographic control indicated plasma cell neoplasia. Chen et al. reported a sensitivity of PET/CT nearly equivalent to that of MRI for the detection of extramedullary lesions; however, they added that in some areas, the use of both techniques could offer complementary information [4] . It must be noted that small lesions with a subcentimeter size may not be detectable on 18F-FDG PET, due to volume averaging in relation to the limited spatial resolution of the PET scanner [5] . This case report confirms the presumption of Chen et al. and reflects the high disease heterogeneity in patients with MM.
